EEF2K and neoplasm: miRNA-22 has been shown to be downregulated in TNBC, reducing inhibitory control over the eukaryotic elongation 2 factor kinase (eEF2K), a tumor growth-promoting and chemoresistance-inducing protein (12, 19).